Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 1315INDUSTRY 938NIH 197NETWORK 64FED 25UNKNOWN 4OTHER_GOV 4INDIV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Other hematologic neoplasm 1Breast 1

Conditions

Rectal Neoplasms 2Colorectal Neoplasms 2

Interventions

Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Has results × Gastrointestinal × Clear all
NCT02295774 2018-11-05

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

CosmoTech

Phase 2 Completed
10 enrolled 6 charts
Gastrointestinal

Colorectal Neoplasms

NCT01694966 2017-11-06

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

CosmoTech

Phase 3 Completed
1,249 enrolled 8 charts
Gastrointestinal

Colorectal Neoplasms

NCT01584544 2015-04-20

Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer

ChineseAMS

Phase 1 Completed
24 enrolled 10 charts
Gastrointestinal

Rectal Neoplasms

NCT01268943 2015-04-06

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

ChineseAMS

Phase 1 Completed
18 enrolled 10 charts
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡